Nasal Naloxone for Narcotic Overdose
Status unconfirmed · Phase 4
Conditions studied: Drug Overdose
In brief
The goal of this study is to determine if nasal naloxone is inferior to standard care for naloxone administration in a pre-hospital setting. Ambulance squads in Adams, Clermont, and Scioto counties in southern Ohio will be randomized to provide either standard care or nasal (IN) naloxone as the initial response to a suspected opioid overdose. Standard care includes administration of naloxone by intravenous (IV), intramuscular (IM) or intraosseus (IO) methods.
Key facts
- Study ID
- NCT01912573
- Run by
- Judith Feinberg
- People needed
- 236
- Starts
- 2013-09-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2013-07-31
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Presence of hyperventilation or respiratory arrest OR
- EMS assessment that the person needs naloxone for possible opioid or unknown drug overdose
You may not qualify if…
- EMS assessment that the participant is less than 12 years old
Where it is running
- Clermont County — Batavia, Ohio, United States
- Scioto County — Portsmouth, Ohio, United States
- Adams County — West Union, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.